Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone
Year: 2019
Type: article
Institutions: Roswell Park Comprehensive Cancer Center, Medizinische Hochschule Hannover, Instituto de Salud Carlos III, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red de Cáncer, Cleveland Clinic, Cedars-Sinai Medical Center, Hospital Del Mar, Vall d'Hebron Hospital Universitari, Pfizer (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2970625285
